OVK — Cytokeratin Fragments 21-1 Eia Kit Class II

FDA Device Classification

Classification Details

Product Code
OVK
Device Class
Class II
Regulation Number
866.6010
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K250925fujirebio diagnosticsADVIA Centaur Cytokeratin Fragment 21-1December 16, 2025
K160915roche diagnosticsElecsys CYFRA 21-1, Elecsys CYFRA 21-1 CalSet, PreciControl Tumor MarkerDecember 14, 2016
K100831fujirebio diagnosticsCYFRA 21-1 EIA MODEL 211-10May 26, 2011